{"transactions":[{"id":2677485,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":138528,"kind":"person","name":"Stafslien Joan","position":1,"cik":"0001467816","reported_name":"Stafslien Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T20:06:34.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reported shares represents a grant of restricted stock awards (the \"RSAs\") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) June 4, 2022, or (ii) the day prior to the date of the Stockholder's Annual Meeting next following June 4, 2021, subject to the\nreporting person's continued service."}],"balance_after":8410,"source":{"system":"sec-edgar","filing":"0001209191-21-039054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467816/000120919121039054/doc4.xml","form_type":"4"}},{"id":2973107,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":138528,"kind":"person","name":"Stafslien Joan","position":1,"cik":"0001467816","reported_name":"Stafslien Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T18:29:15.000Z","date":"2020-11-19","kind":"purchase","acquired":true,"shares":4410,"price":5.6695,"value":25002.495,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 4,410 shares purchased in the price range of $5.54 to $5.80 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held of record by the Thomas & Joan Stafslien Family B Trust dated 6/17/1997, for which the reporting person serves as trustee."}],"balance_after":4410,"source":{"system":"sec-edgar","filing":"0001209191-20-059505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467816/000120919120059505/doc4.xml","form_type":"4"}},{"id":3007153,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":138528,"kind":"person","name":"Stafslien Joan","position":1,"cik":"0001467816","reported_name":"Stafslien Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-14T17:57:41.000Z","date":"2020-10-12","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reported shares represents a grant of restricted stock awards (the \"RSAs\") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) October 12, 2021, or (ii) the day prior to the date of the Annual Meeting next following October 12, 2020, subject to the reporting person's continued service."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001209191-20-054824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467816/000120919120054824/doc4.xml","form_type":"4"}},{"id":3167357,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":138528,"kind":"person","name":"Stafslien Joan","position":1,"cik":"0001467816","reported_name":"Stafslien Joan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-29T09:04:10.000Z","date":"2020-04-27","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reported shares are represented by restricted stock units (\"RSUs\"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. Beginning on April 24, 2021, 1/3 of the RSUs shall vest annually, so that the RSUs will be fully vested on April 24, 2023, subject to the reporting person's continued service through each such vesting date."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-20-026094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1467816/000120919120026094/doc4.xml","form_type":"4"}},{"id":3670623,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":138528,"kind":"person","name":"Stafslien Joan","position":1,"cik":"0001467816","reported_name":"Stafslien Joan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former EVP and General Counsel"}}],"security":"PRSUs","published_at":"2019-02-07T17:56:01.000Z","date":"2018-02-07","kind":"grant","acquired":true,"shares":7929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Performance Restricted Stock Unit (\"PRSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This PRSU award was granted to the Reporting Person on March 1, 2017. The award was granted with a performance condition based on the Issuer's earnings per share over the performance period ended December 31, 2017. On February 7, 2018, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 7,929 shares on March 1, 2020, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. Due to an administrative error, a Form 4 reporting the certification of the performance condition was not filed in February 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This PRSU award was granted to the Reporting Person on March 1, 2017. The award was granted with a performance condition based on the Issuer's earnings per share over the performance period ended December 31, 2017. On February 7, 2018, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 7,929 shares on March 1, 2020, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. Due to an administrative error, a Form 4 reporting the certification of the performance condition was not filed in February 2018."}],"balance_after":7929,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7929},"source":{"system":"sec-edgar","filing":"0001209191-19-008195","document":"doc5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919119008195/doc5.xml","form_type":"5"}},{"id":4457411,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":138528,"kind":"person","name":"Stafslien Joan","position":1,"cik":"0001467816","reported_name":"Stafslien Joan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"PRSUs","published_at":"2017-02-10T17:56:55.000Z","date":"2017-02-08","kind":"grant","acquired":true,"shares":7550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Performance Restricted Stock Unit (\"PRSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This PRSU award was granted to the Reporting Person on October 3, 2016. On February 8, 2017, the Compensation Committee of the Issuer's Board of Directors certified that the PRSU award's performance condition had been satisfied. In accordance with the terms of the PRSU award, the award will vest in full on October 1, 2019. As the PRSU award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This PRSU award was granted to the Reporting Person on October 3, 2016. On February 8, 2017, the Compensation Committee of the Issuer's Board of Directors certified that the PRSU award's performance condition had been satisfied. In accordance with the terms of the PRSU award, the award will vest in full on October 1, 2019. As the PRSU award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant."}],"balance_after":7550,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7550},"source":{"system":"sec-edgar","filing":"0001209191-17-009693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919117009693/doc4.xml","form_type":"4"}},{"id":4569518,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":138528,"kind":"person","name":"Stafslien Joan","position":1,"cik":"0001467816","reported_name":"Stafslien Joan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2016-11-02T18:03:27.000Z","date":"2016-10-31","kind":"purchase","acquired":true,"shares":5000,"price":59.68,"value":298400.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average purchase price from purchase transactions ranging from $59.40 to $59.80. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to Issuer equity awards."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-16-148029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919116148029/doc4.xml","form_type":"4"}}]}